Xencor In Licensing Deal With Merck
socalTECH
JULY 2, 2013
Monrovia-based Xencor announced today that it is in a technology license and option agreement with biotech giant Merck. Xencor said that the deal provides Merck with access to one of its patents for therapeutic monoclonal antibodies. xencor merck licensing patent therapeutic monoclonal antibodies lifescience' READ MORE>>.
Let's personalize your content